This study demonstrated the occurrence of indicine and the isomeric lycopsamine as predominant pyrrolizidine alkaloids in Australian honey; and established a HRAM LC-MS/MS method that chromatographically separated these stereoisomers; enabling the investigation of botanical origin of honey contamination by the respective alkaloids.

1. Introduction {#sec1-toxins-11-00726}
===============

Pyrrolizidine alkaloids (PAs) are secondary metabolites that comprise more than 600 compounds, typified by a pyrrolizidine base with one or more ester linkages. The 1,2-unsaturated PAs are toxic to animals and humans, causing acute and chronic liver and lung damage or cancer and are mainly produced by flowering plant species belonging to the families Asteracaeae (Compositae, tribes Senecioneae and Eupatorieae), Fabaceae (Crotolaria, Chromolaena, Lotonis), Apocynaceae (Echiteae) and Boraginaceae \[[@B1-toxins-11-00726]\], estimated to represent 3% of the Earth's flowering plants \[[@B2-toxins-11-00726]\]. Plants containing pyrrolizidine alkaloids are globally distributed and PAs provide a chemical defence for plants against herbivores. PA biosynthesis has been found to be dependent on many factors, with implications for plant/animal/insect interactions \[[@B3-toxins-11-00726]\]. Various food products can contain toxic PAs either directly from plant origin (certain herbs, herbal medicines) or indirectly through natural transfer from floral nectar and pollen (e.g., some honey, pollen dietary supplements) or inadvertent cross-contamination (e.g., grains, herbs, teas) \[[@B4-toxins-11-00726]\]. The Australian provisional tolerable daily intake of pyrrolizidine alkaloids is 1 µg/kg Bw/day \[[@B5-toxins-11-00726]\], whilst the recommended European accepted intake is 150 times lower at 0.007 µg/kg Bw/day \[[@B6-toxins-11-00726],[@B7-toxins-11-00726],[@B8-toxins-11-00726]\], although this has been recently revised \[[@B9-toxins-11-00726],[@B10-toxins-11-00726]\].

Several studies have described the presence of toxic pyrrolizidine alkaloids (PAs) in honey produced by *Apis mellifera*. Internationally it has been reported that such toxins can be found in honey due to transfer by bees of pollen/nectar from certain flowers, including *Heliotropium*, *Crotolaria*, *Echium* and *Senecio* species. Concern has been raised as to the extent of contamination in Australian honey \[[@B11-toxins-11-00726],[@B12-toxins-11-00726]\] but their presence in Queensland honey has not previously been examined. Previously, investigations into the presence of PAs in Australian honey have concentrated on the introduced pest plant *Echium plantagineum* L. (Paterson's curse) as the major likely PA source \[[@B11-toxins-11-00726],[@B12-toxins-11-00726],[@B13-toxins-11-00726]\]. However, rigorous eradication and biological control programs in recent decades have decreased the prevalence of this weed in Australia \[[@B14-toxins-11-00726]\]. Diverse PA containing plant species occur in Australian pastures and have intoxicated grazing horses, cattle, sheep or pigs and poultry fed contaminated grains \[[@B15-toxins-11-00726],[@B16-toxins-11-00726]\] and include both native and introduced *Crotalaria, Heliotopium* and *Senecio* species \[[@B17-toxins-11-00726]\]. Additionally, native Australian *Parsonsia* species grow in rainforests and on the margins of rainforest/eucalypt forest and contain PAs known to be sequestered by butterflies \[[@B18-toxins-11-00726],[@B19-toxins-11-00726],[@B20-toxins-11-00726]\]. *Parsonsia* species spread from tropical and subtropical Asia to Australia and the south-west Pacific. *Parsonsia straminea* is native to Queensland and New South Wales \[[@B21-toxins-11-00726]\] but there have been no field reports of livestock poisonings \[[@B17-toxins-11-00726]\]. The distribution of these PA containing plants varies throughout the country and different alkaloids would be expected in honey from tropical/sub-tropical Queensland regions as compared to honey originating from southern temperate states. Given that honey represents a significant food source of human exposure to PAs \[[@B10-toxins-11-00726]\], identification of plant PA sources to reduce this exposure is crucial.

In this study of market honey, samples have been identified with alkaloid profiles that appeared to be consistent with a number of PA containing plant species present within the Australian environment. This study examines the presence of PAs in a market survey of honey purchased in Queensland with the aim to assess any food safety concern for the consumer of honey and to correlate PAs identified with previously unsuspected plant sources of these alkaloids.

2. Results and Discussion {#sec2-toxins-11-00726}
=========================

2.1. Pyrrolizidine Analysis Method Validation {#sec2dot1-toxins-11-00726}
---------------------------------------------

Pyrrolizidine alkaloid levels in honey/plant material were quantitated by HRAM UHPLC-MS/MS analysis against 30 certified PA standards, through comparison of the precursor parent ion intensity ([Table 1](#toxins-11-00726-t001){ref-type="table"}) to the standard curves, with squared correlation coefficients (R^2^) typically in the range of 0.9932--0.9997. The honey analysis method was validated according to the National Association of Testing Authorities (NATA) guidance document \[[@B22-toxins-11-00726]\]. The method was validated in blank honey, based on results for 10 spiked samples, giving Limits of Reporting (LORs) of 5 ng/g for individual PAs ([Table 2](#toxins-11-00726-t002){ref-type="table"}). The uncertainties given are at the 95% confidence level as required by NATA \[[@B22-toxins-11-00726],[@B23-toxins-11-00726]\]. Note that for multiresidue analyses at these levels, a default standard uncertainty of ±25% RSD at the 95% confidence level is routinely applied by the authors and is used unless there is evidence that the actual uncertainty is greater than this value. Erucifoline, erucifoline *N*-oxide, jacobine *N*-oxide and seneciphylline *N*-oxide consistently gave low recoveries, resulting in high calculated standard uncertainty (% RSD) for these PAs, but which are not unusual for analyses at these levels. The EU recommends ±50% RSD unless it is demonstrated to be a bigger value \[[@B24-toxins-11-00726]\]. The uncertainty values are calculated at the LOR because it is expected that this level will be the worst case scenario. A small peak was present in the blank for trichodesmine, explaining the higher LOD/LOR and increased uncertainty for this compound.

2.2. Alkaloid Levels Measured in Honey {#sec2dot2-toxins-11-00726}
--------------------------------------

Honeys purchased in supermarkets, health food shops, and from individual commercial/small-scale producers were analysed and calculated to contain pyrrolizidine alkaloids levels between \<LOR (i.e., below limit of reporting) to ≈3300 ng/g of honey.

[Figure 1](#toxins-11-00726-f001){ref-type="fig"} summarises the results in a histogram, with single PA test results below the limit of reporting (5 ng/g) set equal to zero. PAs were detected in 84% of the honey samples examined (*n* = 465). Notably the mean total PA level of PA-positive samples (280 ng/g) was greater than the median (97 ng/g), indicating that the distribution was skewed, with a prevalence of low values ([Figure 1](#toxins-11-00726-f001){ref-type="fig"}, histogram). Whilst the prevalence of low values is reassuring, the overall distribution of total PA concentration is wide, ranging from \<LOR to ≈3300 ng/g.

2.3. LC-MS/MS Separation of Alkaloids {#sec2dot3-toxins-11-00726}
-------------------------------------

Analysis revealed that the individual PA pattern detected by the LC-MS/MS analysis of honeys was characterised almost exclusively by lycopsamine-type PAs. In this study the lycopsamine-type PAs were represented by standards intermedine (**1**), indicine (**2**) and lycopsamine (**3**) ([Figure 2](#toxins-11-00726-f002){ref-type="fig"}). These diastereomeric PAs cannot be distinguished based on their MS/MS spectra \[[@B26-toxins-11-00726]\], and [Figure 3](#toxins-11-00726-f003){ref-type="fig"} shows the identical mass spectra obtained for standards intermedine (**1**), indicine (**2**) and lycopsamine (**3**) by our described HRAMS method. Given the diastereomeric nature of these alkaloids all parent MH^+^ ions and fragment ions are identical, even with HRAMS. Separation based on retention time (RT) was therefore necessary in order to ascertain the botanical origin of PA contamination in these honeys. In most previous studies of PAs in honey, lycopsamine-type PAs were reported as the sum of unresolved stereoisomers, (including indicine (**2**), intermedine (**1**) and/or lycopsamine (**3**), and even the less common rinderine and echinatine) \[[@B27-toxins-11-00726],[@B28-toxins-11-00726],[@B29-toxins-11-00726],[@B30-toxins-11-00726]\] or partially resolved stereoisomers \[[@B8-toxins-11-00726],[@B31-toxins-11-00726],[@B32-toxins-11-00726],[@B33-toxins-11-00726]\]. Under our initial UHPLC conditions, with a column oven temperature of 40 °C, intermedine (**1**) eluted separately first, but indicine (**2**) and lycopsamine (**3**) co-eluted from the Kinetex XB-C18 UHPLC column. Notably the combined indicine/lycopsamine (**2**/**3**) peak represented 75% of the alkaloids present in Queensland honey. As these two alkaloids originate from distinctly different PA plant sources, our aim was to be able to separately quantify the levels of each of these PAs in honey to enable the major plant source of PA contamination to be identified.

Ultimately, separation of indicine/lycopsamine (**2**/**3**) was achieved by simply adjusting the column temperature to 5 °C. A more complicated 'multiple heart-cutting two dimensional chromatography' method has previously been reported for the resolution of multiple PA isomer pairs \[[@B34-toxins-11-00726]\], but in our hands the simple gradient elution at 5 °C was sufficient to achieve our desired resolution of indicine/lycopsamine (**2**/**3**). Under these conditions, of the 30 PAs and PA-NOs all were resolved based on retention time or mass fragmentation of the MS/MS except for intermedine *N*-oxide (**4**) and indicine *N*-oxide (**5**) which displayed identical RT and MS/MS ([Figure 4](#toxins-11-00726-f004){ref-type="fig"}). In plants where these *N*-oxides (**4**) and (**5**) are prevalent, the *N*-oxides could be distinguished by reduction to the corresponding parent alkaloid (**2**/**3**) which were resolved by RT under the described conditions.

2.4. Predominant Alkaloids Present in Queensland Honeys {#sec2dot4-toxins-11-00726}
-------------------------------------------------------

Analysis of all 465 honeys under our optimised LC-MS/MS conditions revealed that the predominant pyrrolizidine alkaloid present in our Queensland honey samples was lycopsamine (**3**), which represented approximately 51% of the measured alkaloid content, followed by indicine (**2**) at 24%, lycopsamine *N*-oxide (**6**) at 9%, intermedine (**1**) at 6% and echimidine (**7**) at 3% ([Figure 5](#toxins-11-00726-f005){ref-type="fig"}). Even though we did not resolve intermedine *N*-oxide (**4**) and indicine *N*-oxide (**5**), the identity of the minor *N*-oxide in individual honey samples was inferred by the presence of the co-occurring parent alkaloid (either intermedine (**1**) or indicine (**2**)).

In individual honeys, lycopsamine (**3**) was detected at up to ≈3100 ng/g, indicine (**2**) at up to 1700 ng/g, with the highest total PA content in any individual honey of ≈3300 ng/g which contained mainly a mixture of lycopsamine (**3**) and lycopsamine *N*-oxide (**6**).

[Figure 6](#toxins-11-00726-f006){ref-type="fig"} shows a Tukey box and whisker plot of the pyrrolizidine alkaloids detected in honeys (*n* = 465), showing the distribution of each PA concentration, for positive samples only. The largest variation was observed for lycopsamine (**3**), indicine (**2**) and lycopsamine *N*-oxide (**6**). In honeys where lycopsamine (**3**) and its *N*-oxide (**6**) were abundant these were generally the dominant PAs (\>90% of PAs detected).

Similarly, in honeys where indicine (**2**) and its *N*-oxide (**5**) were abundant these were generally the dominant PAs (\>68% of PAs detected). In order to explain the relative predominance of these diastereomeric PAs in different honeys, it was clear that we had to identify two main and distinctly different PA plant sources.

2.5. Plant Sources of Indicine *(**2**)* in Honey {#sec2dot5-toxins-11-00726}
-------------------------------------------------

An examination of the locally abundant weed *Heliotropium amplexicaule* (Blue heliotrope) by our LC-MS/MS method revealed that indicine (**2**) and indicine *N*-oxide (**5**) were the predominant pyrrolizidine alkaloids in this plant, and examination of more minor components including the newly identified helioamplexine (**8**) provided a unique fingerprint in the HRAM LC-MS/MS profile \[[@B25-toxins-11-00726]\]. Interrogation of the pyrrolizidine alkaloid profile from market honey samples with high amounts of indicine (**2**), demonstrated that there was strong correlation between the honey PA profile and the *H. amplexicaule* plant alkaloid profile. The presence of both major and minor *H. amplexicaule* alkaloids in this honey provided strong evidence that this plant represented the floral source for this alkaloid contamination \[[@B25-toxins-11-00726]\].

2.6. Plant Sources of Lycopsamine *(**3**)* in Honey {#sec2dot6-toxins-11-00726}
----------------------------------------------------

We similarly sought to understand the source of lycopsamine (**3**) (and its *N*-oxide (**6**)), the major PA observed in Queensland honey. Examination of the PAs co-occurring with lycospamine (**3**) and lycopsamine *N*-oxide (**6**), in the source plant would enable us to establish a unique floral PA fingerprint that could be correlated with PAs observed in honey. In past studies, *Echium plantagineum* L. (Paterson's curse) has been named as the source of lycopsamine (**3**) in Australian honey \[[@B35-toxins-11-00726]\], despite the fact lycopsamine (**3**) is usually only a minor alkaloid in *Echium* spp. \[[@B11-toxins-11-00726],[@B27-toxins-11-00726],[@B36-toxins-11-00726],[@B37-toxins-11-00726]\]. In fact, a previous European study noted the presence of high amounts of lycopsamine (**3**) (607 ng/g) compared to low amounts of echimidine (**7**) (15 ng/g) in imported Australian honeys, and postulated an unknown plant source as a possible interpretation \[[@B27-toxins-11-00726]\]. Indeed our analysis of *E. plantagineum* revealed that after Zn reduction echimidine (**7**) and echiumine were the dominant PAs, with both lycopsamine (**3**) and intermedine (**1**) present in much lower quantities. Clearly *E. plantagineum* is not the major source of lycopsamine (**3**) seen in our Queensland honeys, which is also consistent with the more temperate distribution of this species within Australia \[[@B38-toxins-11-00726]\]. Other species/genera known internationally to contain lycopsamine (**3**) (and intermedine (**1**)) include *Anchusa off*., *Borago off., Lithospermum* spp., and *Symphytum* spp., and *Eupatorium* spp. \[[@B39-toxins-11-00726]\], and are generally not geographically distributed within Australia \[[@B40-toxins-11-00726]\]. They can logically be excluded as potential lycopsamine (**3**) floral sources.

When considering PA species which are known to be prevalent in Queensland, both *Ageratum* and *Aminscka* spp. have been reported to contain lycopsamine (**3**). *Ageratum conyzoides* for example has been reported to contain lycopsamine (**3**) and echinatine \[[@B41-toxins-11-00726],[@B42-toxins-11-00726]\] or lycopsamine (**3**) and 3′-*O*-acetyllycopsamine \[[@B43-toxins-11-00726]\]. A targeted screen by Avula reported lycopsamine (**3**) and its *N*-oxide (**6**) as the two major PAs, together with minor amounts of dihydrolycopsamine, dihydrolycopsamine *N*-oxide and echinatine \[[@B1-toxins-11-00726],[@B44-toxins-11-00726]\]. The closely related *Ageratum houstonianum* is locally abundant in Queensland, and our analysis of Zn reduced plant extract revealed the predominance of retrohoustine, heliohoustine and tentatively echinatine (ratio 2.7:1.7:1 respectively), with much lower amounts of lycopsamine (**3**) and intermedine (**1**) (data not shown). This result is consistent with analysis of this same species from Mexico that showed that lycopsamine (**3**) was not the predominant pyrrolizidine alkaloid present with three other pyrrolizidine alkaloids (retrohoustine, heliohoustine and isoretrohoustine) isolated in greater amounts than lycopsamine (**3**) \[[@B45-toxins-11-00726]\]. Lycopsamine (**3**) and intermedine (**1**) have also been identified in *Amscinckia* spp. \[[@B46-toxins-11-00726]\], with NMR analysis revealing the relative proportion of intermedine (**1**) to lycopsamine (**3**) varied from roughly 2:1 to 1:2 in *A. intermedia, A. hispida,* and *A. lycopsoides*. *Amsinckia* spp. are however regionally controlled as noxious weeds in Australia, and not likely to be a widely abundant PA sources in Queensland. The invasive aquatic weed *Gymnocoronis spilanthoides* has been recently been shown \[[@B47-toxins-11-00726]\] to contain predominantly lycopsamine (**3**) followed by intermedine (**1**), however, this species is also controlled by government eradication programs. None of these plant species matched either the predominant lycopsamine (**3**) profile observed in our Queensland sourced honey or the regional abundance of plant species.

Historically lycopsamine (**3**) was identified in the hair pencil of Australian danaid butterflies in Queensland in a region where *Amsinckia* plants are rare \[[@B48-toxins-11-00726]\]. An examination of the native vines *Parsonsia straminea* (family Apocynaceae) and *Parsonsia eucalyptophylla*, by these authors revealed the presence of lycopsamine (**3**) and intermedine/indicine (**1** or **2**), and acetyl derivatives. As native *Parsonsia* species occur widely in Queensland this species was deduced as the source of lycopsamine (**3**) in danaid butterflies \[[@B49-toxins-11-00726]\]. Lycopsamine-type PAs have been identified in a number of species in Apocynaceae \[[@B50-toxins-11-00726]\].

Interestingly, in a study of butterfly food plants, a comparison of *Parsonsia straminea* flowers revealed the ratio of lycopsamine *N*-oxide (**6**) to intermedine *N*-oxide (**4**) to other alkaloids of 98:1:1. By contrast, *Ageratum sp.* gave a predominance of two M+ 269 isomers compared to lycopsamine (**3**) (45:48:1) \[[@B51-toxins-11-00726]\]. Evidently, lycopsamine (**3**) and intermedine (**1**) and their *N*-oxides are present in a wide variety of plant species, but we sought to identify an origin for the almost exclusive predominance of lycopsamine (**3**) (and its *N*-oxide (**6**)) and these literature reports of *Parsonsia* provided the best clue.

2.7. Pyrrolizidine Alkaloids Determined in Parsonsia Vines {#sec2dot7-toxins-11-00726}
----------------------------------------------------------

Local *Parsonsia straminea* (Qld Herbarium ID AQ522465) was collected and re-examined for PA content using our described HRAM LC-MS/MS method. The plant pyrrolizidine alkaloids were present primarily as the *N*-oxides (96% in the leaves and stems, 99% in the pods, 93% in the nectar and 80% in the pollen). The plant pyrrolizidine alkaloids were analysed with and without reduction by Zn to enable comparison with the honey alkaloids (primarily free alkaloids) as previously observed \[[@B25-toxins-11-00726],[@B52-toxins-11-00726]\]. The SCX SPE methodology was previously demonstrated to be suitable for plant extracts \[[@B36-toxins-11-00726]\]. The investigations aimed to determine for the first time whether and to what extent PAs found in honey are sourced from *Parsonsia straminea* (or closely-related *Parsonsia* species, a number of which are widespread in coastal regions of eastern Australia \[[@B53-toxins-11-00726]\]). High resolution accurate mass (HRAM) data, combined with RT comparison with pyrrolizidine alkaloids standards enabled identification of the major pyrrolizidine alkaloids in *P. straminea* ([Table 3](#toxins-11-00726-t003){ref-type="table"}).

In the *P. straminea* nectar, the ratio of lycopsamine (**3**) and its *N*-oxide (**6**) to intermedine (**1**) and its *N*-oxide (**4**) was \>45--50:1, in the flowers it was 78:1, in anthers/pollen \>50:1, in the pods it was \>50:1, whilst in the leaves, \~3:1.

Minor peaks after reduction were tentatively identified by analysis of the HRAM data ([Table 4](#toxins-11-00726-t004){ref-type="table"}) and corresponded to tessellatine (**9**) or isomer (a C7 isomer, found 300.1801, calculated for C~15~H~25~NO~5~+H^+^: 300.1805), a further C9 lycopsamine isomer (found 300.1803, calculated for C~15~H~25~NO~5~+H^+^: 300.1805), 3′-*O*-acetyllycopsamine (found 342.1905, calculated for C~17~H~28~NO~6~+H^+^: 342.1917), 3′-*O*-acetylintermedine (found 342.1924, calculated for C~17~H~28~NO~6~+H^+^: 342.1917) and two helioamplexine isomers (found 314.1958 and 314.1958, calculated for C~16~H~27~NO~5~+H^+^: 314.1962). The corresponding *N*-oxides were found in the non-reduced plant extract. Tessellatine (**9**) has the same necic acid as lycopsamine (**3**) but is esterified at the C7 necine position rather than C9 as seen in lycopsamine (**3**). The C7 esterification is evidenced in the predominant (base peak) fragment ion *m*/*z* 156.1019 (calculated for C~8~H~14~NO~2~^+^ 156.1019) characteristic of C7 monoesters \[[@B54-toxins-11-00726],[@B55-toxins-11-00726]\], which display much smaller peaks at *m*/*z* 138.0913, 120.0809 and 94.0656 than C9 monoesters lycopsamine (**3**)/indicine (**2**)/intermedine (**1**). The diastereomeric 3′-*O*-acetyllycopsamine and 3′-*O*-acetylintermedine exhibited a similar MS breakdown to that seen in 3′-*O*-angelylindicine \[[@B25-toxins-11-00726]\], with a base peak of *m/z* 94.0655 and other typical peaks of C9 monoesters of retronecine, 156.1019, 138.0913 and 120.0809. In these acetyl compounds, the lack of a peak at *m*/*z* 198.1125 and the lack of a base peak at *m*/*z* 214.1074 in the corresponding *N*-oxides, excluded the 7-*O*-acetyl substitution pattern \[[@B1-toxins-11-00726],[@B56-toxins-11-00726]\]. Similarly the two helioamplexine isomers had identical MS to that seen in helioamplexine (**8**) (the C-6′ homoanalogue of indicine) \[[@B25-toxins-11-00726]\], and these components present in *P. straminea* which did not co-elute with helioamplexine were deduced to be the corresponding C-6′ homoanalogues of lycopsamine and intermedine.

Interestingly, PAs tentatively assigned as 3′-*O*-glucosyllycopsamine (found 462.2336, calculated for C~21~H~35~NO~10~+H^+^: 462.2336) and 3′-*O*-glucosylintermedine (found 462.2335, calculated for C~21~H~35~NO~10~+H^+^: 462.2336) and the corresponding *N*-oxides (found 478.2286 and 478.2289, calculated for C~21~H~35~NO~11~+H^+^: 478.2283), were also identified in minor amounts in the pods and nectar ([Table 4](#toxins-11-00726-t004){ref-type="table"}). The MS^2^ spectra exhibited virtually identical MS^2^ to the parent alkaloids **1** and **3**, **4** and **6**. A 3′-glucopyranosyl 2,3-dihydro-1*H*-pyrrolizin-1-one derivative has previously been reported from *Cynoglossum gansuense* \[[@B57-toxins-11-00726]\]. Additionally, five isomeric components with MH^+^ 286.1649 were also detected in *P. straminea* reduced extracts, with MS data consistent with these being desmethyl analogues of lycopsamine, i.e ideamine A (**10**) isomers (four esterified at C9, one at C7). Ideamine A *N*-oxide has previously been found in insects feeding on *Parsonsia laevigata* leaves \[[@B58-toxins-11-00726],[@B59-toxins-11-00726]\]. Tessellatine (**9**), 3′-*O*-acetyl- and 7-*O*-acetyllycopsamine/intermedine and their *N*-oxides have been previously identified in *Amsinckia* or *Cryptantha* species \[[@B54-toxins-11-00726],[@B55-toxins-11-00726],[@B60-toxins-11-00726],[@B61-toxins-11-00726]\]. To positively identify the PAs in lycopsamine-rich honey samples as originating from *Parsonsia straminea*, we sought to find some of these same minor PA components of this plant in honey.

2.8. Honey PA Profiles Linked to P. straminea {#sec2dot8-toxins-11-00726}
---------------------------------------------

The detection of minor alkaloids in *Parsonsia straminea* provides a distinctive PA fingerprint in its HRAM LC-MS/MS profile, albeit in minor quantities compared to the major alkaloid lycopsamine (**3**). By comparison with the PA profile observed in market honey samples, there is clear evidence that this plant species is being used as a honey floral source by bees ([Figure 7](#toxins-11-00726-f007){ref-type="fig"}).

Honey samples such as H-PA\#146 and H-PA\#157 were independently purchased. When these honey samples were analysed against the 30 PA standards in our screen ([Table 1](#toxins-11-00726-t001){ref-type="table"}), only the major alkaloid lycopsamine (**3**) and lesser intermedine (**1**) (and their *N*-oxides) were detected ([Table 3](#toxins-11-00726-t003){ref-type="table"}). Characteristic major/minor components present in certain honeys ([Table 4](#toxins-11-00726-t004){ref-type="table"}) included in addition to lycospamine and intermedine, the helioamplexine isomers at RT 8.20, 8.44 and 9.38 min ([Figure 8](#toxins-11-00726-f008){ref-type="fig"}) and putative 3′-*O*-acetylintermedine (8.91 min) and 3′-*O*-acetyllycospamine (9.64 min). The tentatively assigned 3′-*O*-glucosylintermedine and 3′-*O*-glucosyllycopsamine were also identified in these honey samples with the MS^2^ spectra observed identical to that found in the plant pods and nectar. Non-toxic dihydrolycopsamine isomers were also identified in the plant and honey. Due to the low levels of these minor PAs in the plant, they were seen most readily in honey samples highest in lycopsamine (**3**) (eg., H-PA\#19,157,146).

2.9. Plant Origins of PAs in Honeys Surveyed {#sec2dot9-toxins-11-00726}
--------------------------------------------

Of the 30 PA standards utilised in our survey, fifteen PAs (50%) were not detected in any of the market honey samples ([Table 5](#toxins-11-00726-t005){ref-type="table"}). As shown in [Table 5](#toxins-11-00726-t005){ref-type="table"}, based on profiles of alkaloids identified, most of the honey PAs were likely sourced from *Parsonsia straminea* or *Heliotropium amplexicaule*, with honey containing *Parsonsia* alkaloids being dominant in lycopsamine (**3**) (up to 3100 ng/g) and honey containing *Heliotropium amplexicaule* alkaloids dominant in indicine (**2**) (up to 1700 ng/g). PAs sourced from *Echium plantagineum* were much lower, with the dominant PA detected being echimidine (**7**) (up to 260 ng/g) in agreement with previous studies \[[@B11-toxins-11-00726],[@B62-toxins-11-00726]\]. Even lower levels of PAs from *Heliotropium europaeum* (containing lasiocarpine, heliotrine and europine \[[@B11-toxins-11-00726],[@B62-toxins-11-00726]\] (and their *N*-oxides)) and Senecio species (most likely *Senecio madagascariensis*) \[[@B63-toxins-11-00726]\] were detected ([Table 5](#toxins-11-00726-t005){ref-type="table"}). Of course, many of the honey samples are ascribed by their label to particular non-PA producing floral sources, so the observation of PAs in these honeys is a product of either the natural foraging of bees on different available plants, or the blending of honeys in the packaging process. This co-foraging/blending is also evident in honey samples that show co-occurrence of pyrrolizidine alkaloids from multiple floral sources, for example, honeys containing indicine (**2**) (from *H. amplexicaule*) and lycopsamine (**3**) (likely from *P. straminea* due to lack of the dominant PA echimidine (**7**) as present in *E. plantagineum*). Both these sets of PAs were present in significant levels in H-PA\#11, 32, 216, 630 and 642. Geographically both the low-growing heliotrope, *H. amplexicaule*, and the arboreal vine, *P. straminea*, can co-occur in sub-tropical coastal regions of Queensland \[[@B53-toxins-11-00726],[@B64-toxins-11-00726]\], so the co-occurrence of their respective alkaloids in honey would seem logical if both plants are visited by foraging bees within the same landscape. The high abundance of alkaloids from these quite different plant species in honey suggests that both are attractive to foraging bees, and where possible both species should be avoided when siting honey hives. It is apparent that the 'standard set' for PA/PANO testing of honeys varies depending on the natural flora of the region, as well as the cultivated plants present. In this study erucifoline, jacobine, monocrotaline, senciphylline, or their corresponding *N*-oxides and senkirkine or trichodesmine were not found in the honey tested, which is a considerably different result to those found recently in Schleswig-Holstein region of Germany \[[@B28-toxins-11-00726]\].

2.10. Honey as a Dietary Source of Pyrrolizidine Alkaloids {#sec2dot10-toxins-11-00726}
----------------------------------------------------------

Major supermarket honeys by comparison represent blended honeys from diverse locations, some of which attributed the specific floral source and in general contained only low levels of PAs. It has been observed previously that blended retail honeys had a lower PA content, but that PAs were present in more samples \[[@B65-toxins-11-00726]\]. In this study, for supermarket honeys (*n* = 129), PAs were detected in 84% of honeys, and showed highest total PA levels of 1400 ng/g. For supermarket honeys, the mean total PA level of PA-positive samples was 120 ng/g and the median level was 61 ng/g.

Certain small producer honeys displayed the highest levels of pyrrolizidine alkaloids, with the PA content dependent on the location and attractiveness of PA containing plants to foraging honey bees. Paradoxically, even though analysed PA content of small producer honeys range from \<LOR to an alarming 3000 ng/g, if equal amounts of each of these 205 small producer honeys were blended, the hypothetical resultant mixed honey would have a PA content of only 240 ng/g (i.e., the average PA content of all of these 465 honeys).

It has been observed previously in South American honeys that raw honeys showed greatest variety due to the availability of PA containing plants near to hives \[[@B65-toxins-11-00726]\].

The cumulative toxicity of the 1,2-unsaturated PAs have been demonstrated in animal studies and genotoxicities/tumorigenicities were induced by hepatic metabolism of PAs \[[@B66-toxins-11-00726]\]. Consequently, provisional tolerable daily intakes (PTDI) have been recommended to control the human consumption of PAs \[[@B5-toxins-11-00726],[@B10-toxins-11-00726],[@B39-toxins-11-00726],[@B67-toxins-11-00726]\].

Using the Australian FSANZ provisional tolerable daily intake (PTDI) of 1 μg/kg BW/day, 0% of honeys tested (total *n* = 465) exceeded the limit for a 70 kg adult consuming 20 g of honey per day, but 19% of honeys tested exceeded the limit for a 15 kg child consuming 50 g of honey per day. Applying the lowest recommended PTDI (EFSA, COT, BfR) of 0.007 μg/kg BW/day, 63% of honeys tested exceeded the limit for a 70 kg adult consuming 20 g of honey per day and 84% of honeys tested exceeded the limit for a 15 kg child consuming 50 g of honey per day.

The PA content of honey samples varies with geographical location and climate, determined by the type and distribution of PA containing plants and by the propensity for bees to forage on these plants \[[@B65-toxins-11-00726],[@B68-toxins-11-00726]\]. Lycopsamine (**3**) and intermedine (**1**) are present in many PA-producing plants, with the knowledge of the plants distributed in Australia and the ratio to other PAs present, it is likely that *Parsonsia straminea* is a major contributor to the high PA levels observed in certain honeys in this study. Of course, it is possible that there is more than one PA source of lycopsamine (**3**), with a small portion of lycopsamine contamination of honey potentially originating from *Echium plantagineum* and *Ageratum houstonianium*. Also, there are likely other PA containing plants that have not been considered. It is also possible that not all PAs present in honey have been identified by comparison with standards and by analysis of the top MSMS. Despite the observation that of the PAs tested in experimental rats, lycopsamine (**3**) induced the lowest levels of liver DNA adducts (formed from PA derived reactive pyrrolic metabolites), PA containing plants are the most common poisonous/carcinogenic plants affecting livestock, wildlife and humans \[[@B69-toxins-11-00726]\]. Beekeepers are advised to avoid these known plant genera around the hive/apiary as much as possible to reduce PA contamination in honey.

3. Conclusions {#sec3-toxins-11-00726}
==============

The HRAM LC-MS/MS method for pyrrolizidine alkaloid analysis described here enables the ready resolution of isomeric alkaloids of the lycopsamine-type. The described simple adjustment of column conditions to a lower temperature was effective in resolving the problematic pairs of indicine/lycopsamine alkaloids present in Australian honey. This resolution has enabled us to identify *Parsonsia* vines as a previously unsuspected source of PA contamination in Australian honey. Low temperature chromatographic resolution may have as yet unexplored application in resolving other similar diastereomeric pyrrolizidine alkaloid isomers, of which there are many within the known pyrrolizidine alkaloids, many of which do not have commercially available standards.

4. Materials and Methods {#sec4-toxins-11-00726}
========================

4.1. Chemicals and Solvents {#sec4dot1-toxins-11-00726}
---------------------------

In total, 30 pyrrolizidine alkaloid standards were utilized in a high resolution accurate mass (HRAM) LC-MS/MS screen. Echimidine, erucifoline, europine, heliotrine, indicine, intermedine, jacobine, lasiocarpine lycopsamine, monocrotaline, retrorsine senecionine, seneciphylline, senecivernine, and their respective *N*-oxides, were purchased together with senkirkine and trichodesmine from Phytolab GmbH & Co. KG (Vestenbergsgreuth, Germany) and had a purity \>89%. All other chemicals and solvents were of analytical reagent or HPLC grade purity. Water used for sample preparation and HPLC was Milli-Q purified (Merck Millipore, Darmstadt, Germany).

4.2. Honey Samples {#sec4dot2-toxins-11-00726}
------------------

Honey samples (465 in total) were purchased between September 2016 and December 2017 directly from Queensland supermarkets, fruit shops, local markets, and producers.

4.3. Honey Alkaloid Extraction {#sec4dot3-toxins-11-00726}
------------------------------

Honey samples (1 g) were dissolved in aqueous H~2~SO~4~ (0.05 M, 10 mL) centrifuged and the supernatant applied to preconditioned Agilent SPE Bond Elut 100 mg LRC-SCX columns (Agilent Technologies, Folsom, CA, USA). SPE cartridges were washed with water (10 mL) and methanol (10 mL), and pyrrolizidine alkaloids were then eluted with 3% ammonia in methanol (3 mL). The eluate was evaporated to dryness under nitrogen, and the residue reconstituted in 5% methanol in water (1 mL) for HRAM LC-MS/MS analysis.

4.4. Honey Method Validation {#sec4dot4-toxins-11-00726}
----------------------------

The validation of the method was conducted according to the National Association of Testing Authorities (NATA) guidance document \[[@B22-toxins-11-00726]\]. The method was validated in 3 blank honeys, and based on results for 10 spiked samples at a spiking level of 5 ng/g ([Table 2](#toxins-11-00726-t002){ref-type="table"}), 10 blank samples and 10 non-extracted spike samples and the recoveries determined. Limit of detection (LOD) was calculated as 3*s*. Limit of quantitation was calculated as 9*s*. Limit of reporting was set at the levels the samples were spiked, also the level of the lowest standard used for the calibration curve. The uncertainties given are at the 95% confidence level as required by the NATA \[[@B22-toxins-11-00726],[@B23-toxins-11-00726]\]. Replicate samples were prepared for every tenth honey test sample to assess reproducibility. The difference between replicate samples (coefficient of variance %) was typically 0.12--6.7%. High samples were diluted to levels within the calibration curve and re-run. SPE wash steps and further elutions with 3% ammonia in methanol (3 mL) were analysed for residual PAs and the extraction was found to be exhaustive. [Table 2](#toxins-11-00726-t002){ref-type="table"} shows good recoveries for most PAs.

4.5. Plant Alkaloid Extraction {#sec4dot5-toxins-11-00726}
------------------------------

### 4.5.1. Plant Source {#sec4dot5dot1-toxins-11-00726}

*Parsonsia straminea* was collected from a suburban area in the south of Brisbane and was taxonomically identified by the Queensland Herbarium, with a voucher specimen (AQ522465) incorporated into their collection. The *Parsonsia straminea* foliage sample was a collection of stems and leaves, and was freeze dried, milled and stored frozen prior to analysis. Pods were collected separately and freeze-dried, milled and frozen. Flowers were sampled as both intact flowers (freeze-dried, milled and frozen) or utilized to provide nectar and pollen separately. Nectar was separated from flowers using a microcap capillary, and anthers and pollen were separated from other flower plants with tweezers and desiccated.

### 4.5.2. Foliage and Seed Pod Extracts {#sec4dot5dot2-toxins-11-00726}

Dried milled plant leaves and stems (1 g) and seed pods (1 g) were separately dissolved in methanol (10 mL), vortexed (20 s), shaken (30 min) then centrifuged (4800 rpm, 10 min) and the supernatants removed and concentrated to dryness under nitrogen. The residues were dissolved in aqueous H~2~SO~4~ (0.05 M, 10 mL) centrifuged (4800 rpm, 10 min) and a portion of the supernatants (0.1 mL) were applied to preconditioned Agilent SPE Bond Elut 500 mg LRC-SCX columns. SPE cartridges were washed with water (10 mL) and methanol (10 mL), and pyrrolizidine alkaloids were then eluted with 3% ammonia in methanol (10 mL). The eluate was evaporated to dryness under nitrogen, and the residue reconstituted in 5% methanol in water (1 mL) for HRAM LC-MS/MS analysis.

### 4.5.3. Whole Flower Extracts {#sec4dot5dot3-toxins-11-00726}

Dried and milled flowers (0.1 g) were dissolved in methanol (2 mL), vortexed (20 s), shaken (30 min) then centrifuged (4800 rpm, 10 min) and the supernatant removed and concentrated to dryness under nitrogen. The residue was dissolved in aqueous H~2~SO~4~ (0.05 M, 1 mL), centrifuged (4800 rpm, 10 min) and, for each sample, a portion of the supernatant (0.1 mL) was applied to a preconditioned Agilent SPE Bond Elut 500 mg LRC-SCX column. Each SPE cartridge was washed with water (10 mL) and methanol (10 mL), and pyrrolizidine alkaloids were then eluted with 3% ammonia in methanol (10 mL). The eluate was evaporated to dryness under nitrogen, and the residue reconstituted in 5% methanol in water (1 mL) for HRAM LC-MS/MS analysis.

### 4.5.4. Zinc Reduced Extracts {#sec4dot5dot4-toxins-11-00726}

Another portion of each aqueous H~2~SO~4~ supernatant (0.5 mL) derived from leaves/stems, pods and flowers was treated with Zn dust (100 mg) and stirred (2 h). After centrifugation (4800 rpm, 10 min), a portion of the supernatants (0.1 mL) was applied to a preconditioned Agilent SPE Bond Elut 500 mg LRC-SCX column. Each SPE cartridge was washed with water (10 mL) and methanol (10 mL), and pyrrolizidine alkaloids were then eluted with 3% ammonia in methanol (10 mL). The eluate was evaporated to dryness under nitrogen, and the residue reconstituted in 5% methanol in water (1 mL) for HRAM LC-MS/MS analysis.

### 4.5.5. Floral Nectar Extract {#sec4dot5dot5-toxins-11-00726}

Nectar (22.5 mg) was obtained from fresh flowers using a microcap capillary, dissolved in MeOH (0.5 mL) and diluted 1 in 100 with 5% methanol in water (1 mL) for HRAM LC-MS/MS analysis.

### 4.5.6. Pollen Extract {#sec4dot5dot6-toxins-11-00726}

Dessicated anthers and pollen were placed in hexane and shaken (1 min). The hexane containing pollen was separated from the anthers and evaporated to dryness under nitrogen. The resulting pollen (0.36 mg) was dissolved in 5% methanol in water and diluted as required for LCMS/MS analysis.

4.6. HRAM LC-MS/MS Analysis {#sec4dot6-toxins-11-00726}
---------------------------

Samples were analysed using a Vanquish UHPLC in combination with Q Exactive Orbitrap high resolution accurate mass (HRAM) spectrometry system (Thermo Fisher Scientific, Bremen, Germany). LC-MS/MS separation was achieved on a Kinetex XB-C18 analytical column (100 × 2.1 mm, 2.6 µm, 100 Å) at 5 °C. Analysis conditions: binary solvent system, solvent A (ammonium formate (5 mM) and formic acid (0.1%) and solvent B (95% *v*/*v* methanol/water with ammonium formate (5 mM) and formic acid (0.1%)). Compounds were eluted from the column at 0.3 mL min^−1^ with mobile phase B held at 5% for 3 min followed by linear gradients of B from 5--50% (3--15 min), 50--80% (15--18.5 min), 80--100% (18.5--19 min), where it was held for 30 sec, before reducing from 100--5% over 6 sec, where it was held until stop at 23.5 min. Instrument control, data acquisition and analysis were conducted using Tracefinder 4.1 from Thermo Fisher Scientific. Alkaloid detection was performed by positive electrospray ionisation (ESI) with a spray voltage of 3500 V and a vaporiser temperature of 400 °C. MS analysis run with arbitrary pressures of sheath gas 48, aux gas 11, sweep gas 2, spray voltage 3.5 kV, capillary temperature of 320 °C, auxiliary gas heater at 350 °C and used full scan/dd-MS^2^ mode. Full scans were conducted at a resolution of 70,000 FWHM (at *m*/*z* 200), with an AGC target of 1.00 × 10^6^. The maximum time of accumulating ions per scan event was 10 ms with a scan range of 75--1125 *m*/*z*. Data dependent acquisition (dd-MS^2^) was conducted at a resolution of 17,500 with an AGC target of 1.00 × 10^6^. The maximum time of accumulating ions per scan event was 50 ms. Normalized collision energy (nce) was set to 50% and an isolation window of 1.0 *m*/*z* was utilized. Dynamic exclusion was set to 3 s preventing subsequent triggering of the same ion in data dependent scans. A maximum of 5 most abundant precursors could be selected for dd-MS^2^ per scan event.

Pyrrolizidine alkaloid levels in honey/plant material were quantitated against certified PA standards, with calibration curves obtained for each of the 30 pyrrolizidine alkaloid standards injected at 5, 10, 20, 50 and 100 and 200 ppb (in duplicate/triplicate). Honey or plant extracts were analysed by HRAM LC-MS/MS to detect pyrrolizidine alkaloids and their *N*-oxides by matching of retention time with the corresponding standard and identified by their precursor parent ion (M+H^+^) and confirmed by the detection of product ions ([Table 1](#toxins-11-00726-t001){ref-type="table"}). The identity of these and further alkaloids was assigned by use of the high resolution accurate mass data provided by the Q Exactive mass spectrometer, enabling the determination of elemental composition of parent and fragment ions ([Table 3](#toxins-11-00726-t003){ref-type="table"} and [Table 4](#toxins-11-00726-t004){ref-type="table"}).
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![Histogram showing the frequency of total pyrrolizidine alkaloid concentrations in honey samples (*n* = 465) analysed against all 30 pyrrolizidine alkaloid standards (and isolated helioamplexine \[[@B25-toxins-11-00726]\]).](toxins-11-00726-g001){#toxins-11-00726-f001}

![Structures of predominant PAs (**1**--**8**) observed in honey (*n* = 465), together with structures of minor components tentatively observed in *Parsonsia straminea* (**9**--**10**).](toxins-11-00726-g002){#toxins-11-00726-f002}

![Stereoisomeric pyrrolizidine alkaloids (**a**) intermedine (**1**), (**b**) indicine (**2**), and (**c**) lycopsamine (**3**), with identical high resolution accurate mass spectra.](toxins-11-00726-g003){#toxins-11-00726-f003}

![Extracted ion chromatogram of the 30 pyrrolizidine alkaloid calibration standards, illustrating the separation obtained under the UHPLC method, with column temperature of 5 °C.](toxins-11-00726-g004){#toxins-11-00726-f004}

![Total amount of each pyrrolizidine alkaloid detected against the 30 PA standards.](toxins-11-00726-g005){#toxins-11-00726-f005}

![Tukey box and whisker plot of distribution of each pyrrolizidine alkaloid detected in honey (*n* = 465) (includes results \>5 ng/g only).](toxins-11-00726-g006){#toxins-11-00726-f006}

![HRAM LC-MS/MS chromatograms (*m*/*z* 300.1805, *m*/*z* 316.1755) comparing the major pyrrolizidine alkaloids in *Parsonsia straminea* and honey: (**a**) intermedine (**1**) and lycopsamine (**3**) in *Parsonsia straminea* leaves (Zn reduced) (**b**) intermedine (**1**) and lycopsamine (**3**) *in Parsonsia straminea* flowers (Zn reduced) (**c**) lycopsamine (**3**) and its N-oxide (**6**) in *Parsonsia straminea* flowers (unreduced) (**d**) intermedine (**1**) and lycopsamine (**3**) in honey sample H-PA\#146 (**e**) intermedine (**1**) and lycopsamine (**3**) in honey sample H-PA\#157.](toxins-11-00726-g007){#toxins-11-00726-f007}

![HRAM LC-MS/MS chromatograms (*m*/*z* 314.1911) comparing minor peaks in *Parsonsia straminea* and honey (**a**) isomers of helioamplexine (**8**) in *Parsonsia straminea* leaves (Zn reduced) (**b**) isomers of (**8**) in honey sample H-PA\#146 (**c**) isomers of (**8**) in honey sample H-PA\#157.](toxins-11-00726-g008){#toxins-11-00726-f008}

toxins-11-00726-t001_Table 1

###### 

Details of pyrrolizidine alkaloids used in the Orbitrap analysis of PA containing plants and honey, including formulae, retention times, precursor ions used for quantitation and confirmatory product ions.

  Compound                                                                  Formula           Average R~T~ (min)   Precursor Ion (MH^+^)   Product Ions                                               
  ------------------------------------------------------------------------- ----------------- -------------------- ----------------------- -------------- ---------- ---------- ---------- ---------- ----------
  Echimidine (**7**)                                                        C~20~H~31~NO~7~   12.86                398.2173                120.0809       83.0497    55.0550                          
  Echimidine *N*-oxide                                                      C~20~H~31~NO~8~   12.80                414.2122                396.2004       352.1745   254.1379   220.1326   137.0833   
  Erucifoline                                                               C~18~H~23~NO~6~   6.23                 350.1598                322.1642       220.1329   164.1066   138.0911   120.0807   
  Erucifoline *N*-oxide                                                     C~18~H~23~NO~7~   8.03                 366.1547                278.1386       218.1172   164.1067   136.0756   119.0729   
  Europine                                                                  C~16~H~27~NO~6~   6.97                 330.1911                254.1385       156.1019   138.0914   120.0810   96.0812    
  Europine *N*-oxide                                                        C~16~H~27~NO~7~   7.86                 346.1860                328.1743       270.1328   256.1172   172.0964   155.0937   
  Helioamplexine                                                            C~16~H~27~NO~5~   9.21                 314.1962                156.1017       138.0913   120.0808   94.0655               
  Helioamplexine *N*-oxide                                                  C~16~H~27~NO~6~   10.42                330.1911                172.0966       155.0938   138.0913   111.0913   94.0653    
  Heliotrine                                                                C~16~H~27~NO~5~   9.56                 314.1962                156.1017       138.0913   120.0808   94.0655               
  Heliotrine *N*-oxide                                                      C~16~H~27~NO~6~   10.46                330.1911                172.0966       155.0938   138.0913   111.0913   94.0653    
  Indicine (**2**)                                                          C~15~H~25~NO~5~   6.67                 300.1806                156.1019       138.0914   120.0810   94.0656    82.0657    
  Indicine *N*-oxide (**5**) and intermedine *N*-oxide (**4**) (n.r.) ^a^   C~15~H~25~NO~6~   8.20                 316.1755                226.1437       172.0968   155.0941   138.0914   111.0682   94.0656
  Intermedine (**1**)                                                       C~15~H~25~NO~5~   6.26                 300.1806                210.1488       156.1019   138.0914   120.0810   94.0656    
  Jacobine                                                                  C~18~H~25~NO~6~   6.56                 352.1755                308.1485       280.1539   262.1432   234.1483   155.1063   
  Jacobine *N*-oxide                                                        C~18~H~25~NO~7~   7.91                 368.1704                296.1485       190.1222   139.0989   121.0885   120.0807   
  Lasiocarpine                                                              C~21~H~33~NO~7~   14.92                412.2330                238.1435       156.1020   138.0914   120.0810   94.0656    
  Lasiocarpine *N*-oxide                                                    C~21~H~33~NO~8~   16.14                428.2279                410.2168       352.1746   328.1753   254.1384   220.1333   137.0835
  Lycopsamine (**3**)                                                       C~15~H~25~NO~5~   6.80                 300.1806                156.1017       138.0914   120.0808   94.0655               
  Lycopsamine *N*-oxide (**6**)                                             C~15~H~25~NO~6~   8.65                 316.1755                172.0964       155.0937   138.0911   136.0755   94.0654    
  Monocrotaline                                                             C~16~H~23~NO~6~   2.88                 326.1598                280.1548       237.1354                                    
  Monocrotaline *N*-oxide                                                   C~16~H~23~NO~7~   7.19                 342.1547                314.1590       296.1487   236.1274   137.0833   119.0729   
  Retrorsine                                                                C~18~H~25~NO~6~   9.13                 352.1755                324.1802       138.0913   120.0808   94.0655               
  Retrorsine *N*-oxide                                                      C~18~H~25~NO~7~   9.64                 368.1704                220.1340       154.0862                                    
  Senecionine                                                               C~18~H~25~NO~5~   11.13                336.1806                308.1864       120.0809                                    
  Senecionine *N*-oxide                                                     C~18~H~25~NO~6~   11.83                352.1755                324.1825       220.1332                                    
  Seneciphylline                                                            C~18~H~23~NO~5~   9.52                 334.1649                306.1706       120.0811                                    
  Seneciphylline *N*-oxide                                                  C~18~H~23~NO~6~   10.46                350.1598                322.1656       246.1495                                    
  Senecivernine                                                             C~18~H~25~NO~5~   10.84                336.1806                308.1848       153.0907   138.0911   120.0807   94.0654    
  Senecivernine *N*-oxide                                                   C~18~H~25~NO~6~   11.45                352.1755                324.1795       220.1327   154.0859   136.0755   120.0807   
  Senkirkine                                                                C~19~H~27~NO~6~   13.62                366.1911                168.1020       150.0915                                    
  Trichodesmine                                                             C~18~H~27~NO~6~   8.79                 354.1911                308.1857       223.1203   222.1489   164.1071   121.0889   

^a^ n.r. = not resolved.

toxins-11-00726-t002_Table 2

###### 

Method validation results for pyrrolizidine alkaloids in honey.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Display Name                                                                                 Spiking Level (ng/g)   LOD\     LOQ\     LOR   Units   Recovery (%)   Calculated Standard Uncertainty (% RSD)
                                                                                                                      (3*s*)   (9*s*)                                
  -------------------------------------------------------------------------------------------- ---------------------- -------- -------- ----- ------- -------------- -----------------------------------------
  Echimidine (**7**)                                                                           5                      0.7      2        5     ng/g    88             11

  Echimidine *N*-oxide                                                                         5                      0.5      2        5     ng/g    60             15

  Erucifoline                                                                                  5                      0.7      2        5     ng/g    34             26

  Erucifoline *N*-oxide                                                                        5                      0.5      2        5     ng/g    26             31

  Europine                                                                                     5                      1        2        5     ng/g    98             16

  Europine *N*-oxide                                                                           5                      0.5      1        5     ng/g    94             6

  Heliotrine                                                                                   5                      0.5      0.7      5     ng/g    108            4

  Heliotrine *N*-oxide                                                                         5                      0.2      0.5      5     ng/g    83             2

  Indicine                                                                                     5                      0.5      2        5     ng/g    98             8

  Indicine *N*-oxide (**5**) and intermedine *N*-oxide (**4**) as indicine *N*-oxide (**5**)   5                      0.5      1        5     ng/g    78             7

  Intermedine (**1**)                                                                          5                      0.5      2        5     ng/g    94             8

  Jacobine                                                                                     5                      2        5        5     ng/g    61             30

  Jacobine *N*-oxide                                                                           5                      1        5        5     ng/g    36             51

  Lasiocarpine                                                                                 5                      0.5      1        5     ng/g    82             6

  Lasiocarpine *N*-oxide                                                                       5                      0.5      0.7      5     ng/g    79             6

  Lycopsamine (**3**)                                                                          5                      0.2      0.7      5     ng/g    95             4

  Lycopsamine *N*-oxide (**6**)                                                                5                      0.7      2        5     ng/g    81             14

  Monocrotaline                                                                                5                      2        5        5     ng/g    89             24

  Monocrotaline *N*-oxide                                                                      5                      0.7      2        5     ng/g    89             13

  Retrorsine                                                                                   5                      1        2        5     ng/g    96             13

  Retrorsine *N*-oxide                                                                         5                      0.7      2        5     ng/g    58             22

  Senecionine                                                                                  5                      0.7      2        5     ng/g    90             11

  Senecionine *N*-oxide                                                                        5                      0.5      2        5     ng/g    58             16

  Seneciphylline                                                                               5                      0.7      2        5     ng/g    70             15

  Seneciphylline *N*-oxide                                                                     5                      0.5      1        5     ng/g    16             36

  Senecivernine                                                                                5                      0.5      2        5     ng/g    86             9

  Senecivernine *N*-oxide                                                                      5                      0.7      2        5     ng/g    53             20

  Senkirkine                                                                                   5                      0.5      0.7      5     ng/g    91             5

  Trichodesmine                                                                                5                      3        7        7     ng/g    78             69
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

toxins-11-00726-t003_Table 3

###### 

High resolution accurate mass (HRAM) data for pyrrolizidine alkaloids in *P. straminea* identified by comparison with PA standards.

  Alkaloid                        Typical R~T~ (min)   Molecular Ion Formula         Calculated \[M+H\]^+^   Observed \[M+H\]^+^   Mass Spectral Data (Rel. Int. %)
  ------------------------------- -------------------- ----------------------------- ----------------------- --------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Intermedine (**1**)             6.27                 \[C~15~H~25~NO~5~ + H\] ^+^   300.1805                300.1804              300.1804 (6) 256.1539 (1) 156.1019 (53) 139.0992 (11) 138.0914 (31) 120.0809 (18) 112.0759 (2) 108.0811 (2) 96.0812 (4) 95.0733 (4) 94.0656 (100) 82.0657 (4)
  Lycopsamine (**3**)             6.80                 \[C~15~H~25~NO~5~ + H\] ^+^   300.1805                300.1805              300.1805 (9) 256.1539 (0.3) 156.1020 (59) 139.0993 (13) 138.0915 (31) 120.0811 (19) 112.0760 (3) 108.0813 (1) 96.0813 (5) 95.0734 (5) 94.0656 (100) 82.0657 (6)
  Intermedine *N*-oxide (**4**)   8.19                 \[C~15~H~25~NO~6~ + H\] ^+^   316.1755                316.1752              316.1752 (41) 298.1631 (1) 272.1491 (2) 172.0967 (100) 155.0940 (18) 154.0862 (8) 138.0914 (55) 137.0837 (6) 136.0757 (15) 112.0759 (5) 111.0682 (12) 94.0655 (19) 93.0577 (13) 82.0419 (3)
  Lycopsamine *N*-oxide (**6**)   8.64                 \[C~15~H~25~NO~6~ + H\] ^+^   316.1755                316.1752              316.1752 (46) 298.1653 (1) 272.1491 (2) 172.0967 (100) 155.0940 (17) 154.0862 (10) 138.0913 (63) 137.0835 (6) 136.0758 (17) 112.0759 (5) 111.0681 (13) 94.0655 (22) 93.0577 (16) 82.0419 (4)

toxins-11-00726-t004_Table 4

###### 

High resolution accurate mass (HRAM) data for pyrrolizidine alkaloids in *P. straminea* identified by analysis of fragmentation patterns, together with those identified in honey samples high in lycopsamine (identification in honey indicated by \*).

  Alkaloid                                        Typical R~T~ (min)   Molecular Ion Formula          Calculated \[M+H\]^+^   Observed \[M+H\]^+^   Mass Spectral Data (Rel. Int. %)
  ----------------------------------------------- -------------------- ------------------------------ ----------------------- --------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  \* Tessellatine (**9**) or isomer               6.34                 \[C~15~H~25~NO~5~ + H\] ^+^    300.1805                300.1801              300.1801 (5) 156.1019 (100) 139.0990 (1) 138.0913 (6) 120.0809 (2) 112.0759 (4) 108.0810 (6) 96.0811 (1) 94.0656 (4) 82.0655 (1)
  Lycopsamine isomer (isomer of **3**)            5.91                 \[C~15~H~25~NO~5~ + H\] ^+^    300.1805                300.1803              300.1803 (7) 210.1485 (1) 156.1019 (42) 139.0992 (14) 138.0914 (26) 120.0809 (18) 112.0759 (2) 108.0812 (2) 96.0813 (5) 95.0734 (6) 94.0656 (100) 82.0657 (5)
  \* Helioamplexine isomer I (isomer of **8**)    8.51                 \[C~16~H~27~NO~5~ + H\] ^+^    314.1962                314.1958              314.1958 (7) 270.1704 (0.5) 224.1643 (2) 156.1019 (44) 139.0992 (19) 138.0914 (25) 120.0810 (18) 112.0759 (2) 96.0812 (5) 95.0734 (8) 94.0656 (100) 82.0657 (7)
  \* Helioamplexine isomer II (isomer of **8**)   9.30                 \[C~16~H~27~NO~5~ + H\] ^+^    314.1962                314.1958              314.1960 (5) 270.1698 (0.5) 224.1643 (2) 156.1019 (33) 139.0992 (14) 138.0914 (25) 120.0809 (18) 112.0759 (2) 96.0812 (4) 95.0733 (7) 94.0656 (100) 82.0657 (6)
  \* Helioamplexine isomer (C7-isomer of **8**)   8.34                 \[C~16~H~27~NO~5~ + H\] ^+^    314.1962                314.1959              314.1959 (4) 156.1019 (100) 139.0992 (2) 138.0914 (6) 126.0916 (1) 120.0808 (2) 112.0759 (5) 108.0810 (10) 94.0655 (1) 86.0605 (2) 82.0656 (1) 80.0500 (1)
  \* 3′-*O*-Acetylintermedine                     8.91                 \[C~17~H~27~NO~6~ + H\] ^+^    342.1911                342.1924              342.1924 (1) 282.1700 (4) 156.1019 (16) 139.0991 (7) 138.0913 (17) 120.0809 (20) 108.0812 (1) 96.0812 (2) 96.0450 (2) 95.0734 (3) 94.0655 (100) 82.0657 (3)
  \* 3′-*O*-Acetyllycopsamine                     9.64                 \[C~17~H~27~NO~6~ + H\] ^+^    342.1911                342.1905              342.1905 (1) 282.1703 (2) 156.1019 (14) 139.0992 (3) 138.0913 (19) 120.0809 (19) 108.0812 (1) 96.0812 (2) 96.0448 (1) 95.0734 (2) 94.0655 (100) 82.0657 (3) 67.0549 (1)
  Ideamine A (**10**) isomer I                    2.43                 \[C~14~H~23~NO~5~ + H\] ^+^    286.1649                286.1648              286.1648 (11) 242.1392 (1) 196.1335 (2) 156.1019 (43) 139.0992 (11) 138.0914 (26) 120.0809 (18) 112.0758 (2) 108.0810 (2) 96.0813 (7) 95.0734 (5) 94.0656 (100) 82.0657 (5)
  Ideamine A (**10**) isomer II                   3.70                 \[C~14~H~23~NO~5~ + H\] ^+^    286.1649                286.1649              286.1649 (8) 156.1019 (35) 139.0992 (8) 138.0913 (30) 120.0808 (18) 96.0813 (4) 95.0734 (4) 94.0655 (100) 94.0593 (1) 82.0657 (3) 80.0500 (1) 67.0547 (1)
  Ideamine A (**10**) isomer III                  4.37                 \[C~14~H~23~NO~5~ + H\] ^+^    286.1649                286.1649              286.1649 (0) 156.1018 (46) 139.0992 (7) 138.0913 (26) 120.0807 (17) 98.2419 (3) 95.0733 (3) 94.0656 (100) 93.0705 (3) 82.0655 (4) 67.0549 (4)
  Ideamine A (**10**) isomer IV                   5.10                 \[C~14~H~23~NO~5~ + H\] ^+^    286.1649                286.1651              286.1651 (16) 258.9584 (3) 190.8082 (4) 188.1787 (3) 158.5305 (3) 156.1016 (48) 138.0913 (29) 124.0405 (3) 120.0807 (18) 94.0655 (100)
  Ideamine A C7 isomer                            1.72                 \[C~14~H~23~NO~5~ + H\] ^+^    286.1649                286.1656              286.1656 (10) 156.1019 (100) 138.0915 (5) 124.0757 (2) 120.0813 (1) 112.0760 (5) 108.0811 (7) 106.0656 (4) 94.0651 (2) 86.0603 (1)
  Lycopsamine *N*-oxide isomer                    7.61                 \[C~15~H~25~NO~6~ + H\] ^+^    316.1755                316.1751              316.1754 (46) 172.0967 (100) 155.0940 (21) 154.0862 (13) 138.0914 (94) 137.0836 (8) 136.0757 (25) 112.0759 (8) 111.0681 (14) 108.0811 (6) 94.0656 (35) 93.0577 (24)
  7-Isomer of lycopsamine *N*-oxide               7.19                 \[C~15~H~25~NO~6~ + H\] ^+^    316.1755                316.1751              316.1751 (5) 172.0968 (100) 155.0940 (6) 154.0863 (2) 138.0914 (3) 137.0836 (3) 136.0757 (2) 111.0681 (11) 106.0654 (6) 102.0555 (2) 94.0657 (1)
  Helioamplexine *N*-oxide isomer I               9.87                 \[C~16~H~27~NO~6~ + H\] ^+^    330.1911                330.1908              330.1908 (39) 286.1642 (4) 240.1594 (7) 172.0967 (100) 155.0940 (30) 154.0862 (11) 138.0914 (84) 136.0758 (22) 112.0760 (8) 111.0681 (18) 94.0655 (36) 93.0577 (20) 82.0419 (9)
  Helioamplexine *N*-oxide isomer II              10.63                \[C~16~H~27~NO~6~ + H\] ^+^    330.1911                330.1909              330.1909 (46) 172.0967 (100) 155.0940 (30) 154.0862 (12) 138.0914 (91) 137.0835 (9) 136.0757 (23) 112.0759 (8) 111.0681 (20) 94.0655 (38) 93.0577 (26) 82.0419 (11)
  3′-*O*-Acetyllycopsamine *N*-oxide isomer I     10.25                \[C~17~H~27~NO~7~+ H\] ^+^     358.1860                358.1856              358.1856 (15) 316.1758 (4) 298.1649 (40) 172.0968 (100) 155.0941 (23) 154.0863 (10) 138.0914 (73) 136.0758 (21) 111.0682 (19) 94.0656 (33) 93.0577 (21) 89.0602 (19) 87.0446 (14)
  3′-*O*-Acetyllycopsamine *N*-oxide isomer II    10.92                \[C~17~H~27~NO~7~+ H\] ^+^     358.1860                358.1859              358.1859 (19) 316.1748 (4) 298.1648 (39) 172.0967 (100) 155.0940 (19) 154.0862 (14) 138.0914 (89) 137.0835 (8) 136.0758 (27) 112.0759 (7) 111.0681 (16) 94.0656 (44) 93.0577 (31)
  7-*O*-Acetyllycopsamine *N*-oxide               10.03                \[C~17~H~27~NO~7~+ H\] ^+^     358.1860                358.1857              358.1857 (21) 214.1073 (100) 180.1019 (48) 178.0863 (14) 137.0836 (53) 136.0758 (17) 120.0810 (16) 119.0731 (14) 106.0654 (13) 101.0601 (25) 89.0602 (15) 73.0291 (20)
  Ideamine A *N*-oxide isomer I                   4.87                 \[C~14~H~23~NO~6~+ H\] ^+^     302.1598                302.1595              302.1595 (67) 212.1275 (4) 172.0966 (91) 155.0939 (18) 154.0864 (10) 138.0913 (100) 137.0834 (7) 136.0757 (20) 112.0759 (7) 111.0681 (11) 108.0810 (6) 94.0655 (31) 93.0577 (23)
  Ideamine A *N*-oxide isomer II                  6.27                 \[C~14~H~23~NO~6~+ H\] ^+^     302.1598                302.1596              302.1596 (65) 172.0968 (96) 158.1181 (7) 155.0941 (18) 154.0861 (12) 138.0913 (100) 137.0835 (10) 136.0757 (26) 112.0759 (9) 111.0680 (9) 94.0656 (31) 93.0577 (24)
  \* 3′-*O*-Glucosyllycopsamine                   8.94                 \[C~21~H~35~NO~10~ + H\] ^+^   462.2336                462.2336              300.1806 (12) 156.1021 (16) 139.0994 (4) 138.0915 (40) 120.0810 (16) 97.0289 (3) 96.0813 (2) 96.0451 (2) 94.0657 (100) 85.0290 (7)
  \* 3′-*O*-Glucosylintermedine                   7.41                 \[C~21~H~35~NO~10~ + H\] ^+^   462.2336                462.2335              300.1807 (17) 156.1019 (20) 139.0993 (5) 138.0914 (48) 120.0810 (19) 97.0289 (4) 96.0813 (2) 94.0656 (100) 91.0580 (2) 85.0290 (10)
  \* 3′-*O*-Glucosyllycopsamine *N*-oxide         9.89                 \[C~21~H~35~NO~11~ + H\] ^+^   478.2283                478.2286              316.1754 (100) 172.0968 (90) 155.0941 (15) 154.0860 (10) 138.0914 (74) 137.0837 (6) 136.0758 (19) 120.0809 (6) 112.0762 (5) 111.0680 (7) 94.0657 (47) 93.0578 (12)
  \* 3′-*O*-Glucosylintermedine *N*-oxide         8.58                 \[C~21~H~35~NO~11~ + H\] ^+^   478.2283                478.2289              316.1758 (100) 172.0968 (76) 155.0943 (13) 154.0863 (9) 138.0916 (56) 137.0838 (7) 136.0757 (15) 120.0808 (7) 111.0681 (7) 94.0656 (29) 93.0578 (12)
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###### 

Number of PA positive samples and PA concentration in honey samples (*n* = 465), grouped by potential source of PA plant origin (mean and median are for positive samples only).

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Potential Plant Source of PAs in Honey              Pyrrolizidine Alkaloids                               Number of Honey Samples   PA Content (ng/g)        
  --------------------------------------------------- ----------------------------------------------------- ------------------------- ------------------- ---- ------
  ***Parsonsia straminea*** (Monkey rope)                                                                                                                      

                                                      Lycopsamine                                           274                       210                 33   3100

                                                      Lycopsamine *N*-oxide                                 31                        320                 51   1900

                                                      Intermedine                                           217 ^b^                   32                  18   290

                                                      Intermedine *N*-oxide ^a^                             30 ^c^                    86                  21   660

  ***Heliotropium amplexicaule*** (Blue heliotrope)                                                                                                            

                                                      Indicine                                              221                       120                 31   1700

                                                      Indicine *N*-oxide/intermedine *N*-oxide (n.r.) ^a^   30 ^c^                    86                  21   660

                                                      Intermedine                                           217 ^b^                   32                  18   290

                                                      Helioamplexine ^d^                                    78                        23                  13   130

                                                      Helioamplexine *N*-oxide ^e^                          5                         28                  35   51

  ***Echium plantagineum*** (Paterson's curse)                                                                                                                 

                                                      Echimidine                                            93                        36                  20   260

                                                      Lycopsamine\                                          76 ^f^\                                            
                                                      Intermedine                                           37 ^g^                                             

  ***Heliotropium europaeum*** (Potato weed)                                                                                                                   

                                                      Europine                                              26                        30                  11   160

                                                      Europine *N*-oxide                                    4                         11                  7    24

                                                      Heliotrine                                            17                        23                  15   75

                                                      Heliotrine *N*-oxide                                  1                         9                   9    9

                                                      Lasiocarpine                                          10                        20                  14   59

  ***Senecio* species**                                                                                                                                        

                                                      Senecivernine                                         19                        24                  14   150

                                                      Senecionine                                           7                         13                  8    41

                                                      Retrorsine                                            18                        20                  12   91

  **No occurrence/Below LOR**                                                                                                                                  

                                                      Echimidine *N*-oxide                                  0                                                  

                                                      Erucifoline                                           0                                                  

                                                      Erucifoline *N*-oxide                                 0                                                  

                                                      Jacobine                                              0                                                  

                                                      Jacobine *N*-oxide                                    0                                                  

                                                      Lasiocarpine *N*-oxide                                0                                                  

                                                      Monocrotaline                                         0                                                  

                                                      Monocrotaline *N*-oxide                               0                                                  

                                                      Retrorsine *N*-oxide                                  0                                                  

                                                      Senecionine *N*-oxide                                 0                                                  

                                                      Seneciphylline                                        0                                                  

                                                      Seneciphylline *N*-oxide                              0                                                  

                                                      Senecivernine *N*-oxide                               0                                                  

                                                      Senkirkine                                            0                                                  

                                                      Trichodesmine                                         0                                                  
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Not resolved--indicine *N*-oxide and intermedine *N*-oxide co-eluted. ^b,c^ Intermedine and intermedine *N*-oxide are present in multiple plants, and prominent in both *Parsonsia straminea* and *Heliotropium amplexicaule.* ^d^ Helioamplexine was quantified using heliotrine standard curve. ^e^ Helioamplexine *N*-oxide was quantified using heliotrine *N*-oxide standard curve. ^f^ Lycopsamine observed in honey containing echimidine not necessarily attributed solely to *E. plantagineum*, but of the 93 honey samples containing echimidine, the concentration of lycopsamine was lower than echimidine in 76 honeys, which is consistent with the relative amounts observed in *E. plantagineum*. In the other 17 honeys which contain echimidine, it is likely that there is more than one source of lycopsamine. ^g^ Of the 76 honeys in which lycopsamine was at a lower level than echimidine, 37 honey samples also contained intermedine.
